The effect of Dydrogesterone and Cyclogest on threatend abortio
Phase 3
- Conditions
- Threatened abortion.Threatened abortion
- Registration Number
- IRCT20120104008611N8
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 160
Inclusion Criteria
Gestational age 6 to 13 weeks
Observation of fetal heart rate
Vaginal bleeding
Uterine anomalies
Fetal anomalies
Exclusion Criteria
Patient unwillingness
Breast carcinoma
Lack of fetal heart rate
Severe liver problems
Genital carcinoma
Thromboembolic disorders
Epilepsy
Diabetes
Hypertension
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Threatened abortion. Timepoint: Before intervention and 2 weeks after the completion of the intervention. Method of measurement: Weekly visit.
- Secondary Outcome Measures
Name Time Method Preeclampsia. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and thereafter weekly until delivery. Method of measurement: Mercury Barometer.;Gestational Diabetes. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and then weekly until delivery. Method of measurement: Glucose tolerance test.;Preterm labor. Timepoint: Up to 28 weeks monthly and until 36 weeks every two weeks and then weekly until delivery. Method of measurement: Tocometry of uterus and delivery before 37 weeks of pregnancy.;Low birth weight. Timepoint: Weight immediately after birth. Method of measurement: Pediatric scales.;Abortion under 20 weeks of pregnancy. Timepoint: Every week from the start of the intervention up to 20 weeks of pregnancy. Method of measurement: Questionnaire.